Literature DB >> 16702910

Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial.

Michael Krebs, Karolina Leopold, Christoph Richter, Thorsten Kienast, Axel Hinzpeter, Andreas Heinz, Martin Schaefer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16702910     DOI： 10.1097/01.jcp.0000219926.49799.89

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

1.  A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.

Authors:  Joanne B Fertig; Megan L Ryan; Daniel E Falk; Raye Z Litten; Margaret E Mattson; Janet Ransom; William J Rickman; Charles Scott; Domenic Ciraulo; Alan I Green; Nassima A Tiouririne; Bankole Johnson; Helen Pettinati; Eric C Strain; Eric Devine; Mary F Brunette; Kyle Kampman; David A Tompkins; Robert Stout
Journal:  Alcohol Clin Exp Res       Date:  2012-02-10       Impact factor: 3.455

2.  Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Authors:  Eric W Fish; Abigail E Agoglia; Michael C Krouse; R Grant Muller; J Elliott Robinson; C J Malanga
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

3.  Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review.

Authors:  John J Mariani; Frances R Levin
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

4.  The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study.

Authors:  Ofra Sarid-Segal; Joanna Piechniczek-Buczek; Clifford Knapp; Maryam Afshar; Eric Devine; Laurie Sickles; Emma Uwodukunda; Courtney Richambault; Jillian Koplow; Domenic Ciraulo
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

Review 5.  Alcohol withdrawal syndrome: mechanisms, manifestations, and management.

Authors:  S Jesse; G Bråthen; M Ferrara; M Keindl; E Ben-Menachem; R Tanasescu; E Brodtkorb; M Hillbom; M A Leone; A C Ludolph
Journal:  Acta Neurol Scand       Date:  2016-09-01       Impact factor: 3.209
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.